Država: Sjedinjene Američke Države
Jezik: engleski
Izvor: NLM (National Library of Medicine)
Benztropine Mesylate (UNII: WMJ8TL7510) (Benztropine - UNII:1NHL2J4X8K)
Akorn
Benztropine Mesylate
Benztropine Mesylate 1 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
For use as an adjunct in the therapy of all forms of parkinsonism (see DOSAGE AND ADMINISTRATION). Useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see PRECAUTIONS) due to neuroleptic drugs (e.g., phenothiazines). Hypersensitivity to any component of benztropine mesylate injection, USP. Because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.
Benztropine Mesylate Injection, USP 1 mg per mL, is a clear, colorless solution and is supplied as follows: NDC 17478-012-02 in boxes of 5 x 2 mL ampuls. Storage: Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Akorn Distributed by: Akorn, Inc. Lake Forest, IL 60045 BZ00N Rev. 09/16
New Drug Application Authorized Generic
BENZTROPINE MESYLATE- BENZTROPINE MESYLATE INJECTION AKORN ---------- BENZTROPINE MESYLATE INJECTION, USP RX ONLY DESCRIPTION Benztropine mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine. It is designated chemically as 8-azabicyclo[3.2.1] octane, 3-(diphenylmethoxy)-,_endo_, methanesulfonate. Its empirical formula is C H NO•CH O S, and its structural formula is: Benztropine mesylate is a crystalline white powder, very soluble in water, and has a molecular weight of 403.54. Benztropine mesylate injection, USP is supplied as a sterile injection for intravenous and intramuscular use. Each milliliter of the injection contains: Benztropine mesylate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 mg Sodium chloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 mg Water for injection q.s. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 mL CLINICAL PHARMACOLOGY Benztropine mesylate injection, USP possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism. In the isolated guinea pig ileum, the anticholinergic activity of this drug is about equal to that of atropine; however, when administered orally to unanesthetized cats, it is only about half as active as atropine. 21 25 4 3 In laboratory animals, its antihistaminic activity and duration of action approach those of pyrilamine maleate. INDICATIONS For use as an adjunct in the therapy of all forms of parkinsonism (see DOSAGE AND ADMINISTRATION). Useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see PRECAUTIONS) due to neuroleptic drugs (e.g., phenothiazines). CONTRAINDICATIONS Hypersensitivity to any component of benztropine mesylate injection, USP. Because of its atropine-like side effec Pročitajte cijeli dokument